Anthony Park, Ph.D.
Graduated 2020
Graduated 2020
Current Position: Staff Scientist, City of Hope
Anthony K Park, PhD | LinkedIn
Prior Academic Affiliation: UCSD, Cal Poly Pomona
Thesis Mentor: Stephen J. Forman, Yuman Fong, and Saul J. Priceman
Thesis Title: Effective combination immunotherapy using oncolytic viruses and CAR T cells against solid tumors
Fellowships, honors, awards etc.:CIRM Bridges to Stem Cell Research Program Scholar
Publications:
Park A.K., Y. Fong, N. G. Chen, B. Jeang, D. Tilakawardane, J. P. Murad, S. I. Kim, J. Lu, S. H. Thomas, S. J. Forman, S. J. Priceman. “Effective Combination Immunotherapy using Oncolytic Viruses to Deliver CAR Targets to Solid Tumors.” Manuscript under review
Shyambabu C., A. Yang, S. Kang, J. Lu, S. I. Kim, A.K. Park, V. Sivanandam, Z. Zhang, Y. Woo, S. Warner and Y. Fong. “Oncolytic Poxvirus CF33-hNIS-Δ14.5 Favorably Modulates Tumor Immune Microenvironment and Works Synergistically with anti-PD-L1 Antibody in a Triple Negative Breast Cancer Model.” Manuscript under review
Park A.K., Y. Fong, N. G. Chen, D. Tilakawardane, B. Jeang, J.P. Murad, M. O’Leary, S. J. Forman, S. J. Priceman,. (2017) “Oncolytic viruses effectively deliver chimeric antigen receptor targets to triple negative breast cancers.” Journal for ImmunoTherapy of Cancer 3(Suppl 2):P92.
Park A.K., S. J. Priceman, E. Gerdts, W. C. Chang, S. Wright, S. J. Forman, C. E. Brown. (2015) “Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII).” Journal for ImmunoTherapy of Cancer 3(Suppl 2):P119.
O'Leary, M. P., A. H. Choi, S. I. Kim, S. Chaurasiya, J. Lu, A. K. Park, Y. Woo, S. G. Warner, Y. Fong and N. G. Chen (2018). "Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose." J Transl Med 16(1): 110.
O'Leary, M. P., S. G. Warner, S. I. Kim, S. Chaurasiya, J. Lu, A. H. Choi, A. K. Park, Y. Woo, Y. Fong and N. G. Chen (2018). "A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection." Mol Ther Oncolytics 9: 13-21.
Priceman, S. J., D. Tilakawardane, B. Jeang, B. Aguilar, J. P. Murad, A. K. Park, W. C. Chang, J. R. Ostberg, J. Neman, R. Jandial, J. Portnow, S. J. Forman and C. E. Brown (2018). "Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2(+) Breast Cancer Metastasis to the Brain." Clin Cancer Res 24(1): 95-105.
Priceman, S. J., E. A. Gerdts, D. Tilakawardane, K. T. Kennewick, J. P. Murad, A. K. Park, B. Jeang, Y. Yamaguchi, X. Yang, R. Urak, L. Weng, W. C. Chang, S. Wright, S. Pal, R. E. Reiter, A. M. Wu, C. E. Brown and S. J. Forman (2018). "Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer." Oncoimmunology 7(2): e1380764.
Blumstein GW, Parsa A, Park AK, McDowell BLP, Arroyo-Mendoza M, et al. (2014) “Effect of Delta-9-Tetrahydrocannabinol on Mouse Resistance to Systemic Candida albicans Infection.” PLOS ONE 9(7): e103288. https://doi.org/10.1371/journal.pone.0103288